2023
DOI: 10.1016/j.bcp.2023.115904
|View full text |Cite
|
Sign up to set email alerts
|

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting

Anastasios Lymperopoulos,
Jordana I. Borges,
Renee A. Stoicovy
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 76 publications
0
3
0
Order By: Relevance
“…Another likely regulatory mechanism is G protein signaling (RGS) proteins, which negatively regulate G protein-coupled receptors [ 46 ]. Certain RGS proteins, specifically RGS2 and RGS4, are known to regulate adrenal aldosterone synthesis in response to angiotensin II [ 47 ], and at least RGS2 has been reported to be suppressed by estrogen [ 48 ]. Given that AT 1 R-GPER interferes in the synthesis of aldosterone [ 49 ], it is quite plausible that RGS proteins are also involved in the effects of estrogens on adrenocortical aldosterone production.…”
Section: Molecular Evidence Of Estrogens In the Biosynthesis Of Aldos...mentioning
confidence: 99%
“…Another likely regulatory mechanism is G protein signaling (RGS) proteins, which negatively regulate G protein-coupled receptors [ 46 ]. Certain RGS proteins, specifically RGS2 and RGS4, are known to regulate adrenal aldosterone synthesis in response to angiotensin II [ 47 ], and at least RGS2 has been reported to be suppressed by estrogen [ 48 ]. Given that AT 1 R-GPER interferes in the synthesis of aldosterone [ 49 ], it is quite plausible that RGS proteins are also involved in the effects of estrogens on adrenocortical aldosterone production.…”
Section: Molecular Evidence Of Estrogens In the Biosynthesis Of Aldos...mentioning
confidence: 99%
“…Interestingly, a recent study documented a novel molecular target for dapagliflozin's sympatholytic effects: the adrenal Regulator of G protein Signaling (RGS)-4 upregulation [14]. RGS4 belongs to the superfamily of GTPase-activating proteins (GAPs) for G proteins; i.e., it accelerates G i/o -and G q/11 -protein-signaling termination [15]. RGS4 is abundantly expressed in the adrenal glands, both in the cortex and in the medulla [16], and its genetic deletion in mice is associated with elevated levels of circulating catecholamines, i.e., increased sympathetic activity, and elevated free fatty acid (FFA) levels in the blood [17].…”
mentioning
confidence: 99%
“…Of note, one of the four G-protein-coupled receptors (GPCRs) mediating FFA signaling inside cells [18], FFA receptor type 3 (FFAR3), has been reported to promote norepinephrine release from sympathetic neurons [19], and FFAR3 signaling was recently shown to be inhibited by RGS4 in cardiomyocytes and sympathetic-like neurons [20]. In any case, adrenal RGS4 inhibits cholinergic (vagal)-nerve-stimulated catecholamine release from the chromaffin cells of the adrenal medulla [15,17], making it sympatholytic in this secretory organ. Consequently, dapagliflozin, by transcriptionally upregulating RGS4 in the adrenals [14], can have a direct sympatholytic effect via RGS4 in the adrenal medulla.…”
mentioning
confidence: 99%